4.7 Article

A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Cell Biology

Why Warburg Works: Lactate Controls Immune Evasion through GPR81

Kathrine Lundo et al.

CELL METABOLISM (2020)

Article Cell Biology

MiR-210-3p-EphrinA3-PI3K/AKT axis regulates the progression of oral cancer

Lin Wang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT

Xina Zhang et al.

MOLECULAR CANCER (2019)

Article Multidisciplinary Sciences

FOXK1 and FOXK2 regulate aerobic glycolysis

Valentina Sukonina et al.

NATURE (2019)

Review Biochemistry & Molecular Biology

Metazoan MicroRNAs

David P. Bartel

Article Biochemistry & Molecular Biology

Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer

Steven C. Eastlack et al.

MOLECULAR CANCER (2018)

Article Oncology

The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism

Yixiao Feng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Review Oncology

Breast Cancer Immunotherapy: Facts and Hopes

Leisha A. Emens

CLINICAL CANCER RESEARCH (2018)

Article Chemistry, Multidisciplinary

Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit

Matthew G. Costales et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)

Article Biochemistry & Molecular Biology

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway

Dong Ren et al.

MOLECULAR CANCER (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Review Biotechnology & Applied Microbiology

Cytoglobin as a Biomarker in Cancer: Potential Perspective for Diagnosis and Management

Tatsha C. Bholah et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Genetics & Heredity

DNA damage induced activation of Cygb stabilizes p53 and mediates G1 arrest

Rince John et al.

DNA REPAIR (2014)

Review Cell Biology

Targeting cellular metabolism to improve cancer therapeutics

Y. Zhao et al.

CELL DEATH & DISEASE (2013)

Article Multidisciplinary Sciences

Tumour-associated mutant p53 drives the Warburg effect

Cen Zhang et al.

NATURE COMMUNICATIONS (2013)

Review Biochemistry & Molecular Biology

MYC on the Path to Cancer

Chi V. Dang

Article Biochemistry & Molecular Biology

p53-Independent expression of wild-type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-treated cancer cell lines and human tumors

Ji-Young Park et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Oncology

Regulation of cancer cell metabolism

Rob A. Cairns et al.

NATURE REVIEWS CANCER (2011)

Review Multidisciplinary Sciences

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Matthew G. Vander Heiden et al.

SCIENCE (2009)

Review Biochemistry & Molecular Biology

Hypoxia-inducible factors, stem cells, and cancer

Brian Keith et al.